Tobacco–cannabis co-use among cancer patients and survivors: findings from 2 US cancer centers
Results illustrate the importance of conducting assessments for both tobacco and cannabis use among cancer patients during and after cancer treatment, regardless of the cannabis regulatory environment. Given previous data indicating harms from co-use and continued tobacco use during cancer treatment, this issue introduces new priorities for cancer care delivery and research.
Authors
- Danielle M. Smith (ORCID: https://orcid.org/0000-0002-1637-0992)
- Rachel L. Tomko (ORCID: https://orcid.org/0000-0002-6961-4399)
- Erin A. McClure (ORCID: https://orcid.org/0000-0001-9744-7818)
- Aimee L. McRae‐Clark (ORCID: https://orcid.org/0000-0002-9774-318X)
- Nicolas J. Schlienz (ORCID: https://orcid.org/0000-0003-3665-6776)
- Jennifer Dahne (ORCID: https://orcid.org/0000-0001-7297-9420)
- Andrew Hyland (ORCID: https://orcid.org/0009-0009-6318-9932)
- Kyle J. Walters (ORCID: https://orcid.org/0000-0003-4223-1432)
- Jesse T. Kaye (ORCID: https://orcid.org/0000-0001-6350-4247)
- Rebecca L. Ashare (ORCID: https://orcid.org/0000-0003-4664-009X)
Institutions
- Roswell Park Comprehensive Cancer Center (US)
- University of Wisconsin–Madison (US)
- Medical University of South Carolina (US)
- MUSC Hollings Cancer Center (US)
- Ralph H. Johnson VA Medical Center (US)
- University at Buffalo, State University of New York (US)
Publication Details
- Journal
- JNCI Monographs
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1093/jncimonographs/lgad035
- Citations
- 5
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 2.24
Funders
- Medical University of South Carolina
- National Institutes of Health
- Hollings Cancer Center, Medical University of South Carolina
- National Institute on Drug Abuse
- National Cancer Institute
- National Center for Advancing Translational Sciences